Omega Therapeutics announces collaboration with Stanford University School of Medicine

The development-stage biotechnology company Omega Therapeutics is teaming up with Stanford University to investigate therapies for ocular diseases via control of specific ocular disease genes.

PANOROMA elucidates effects of nonperfusion, leakage areas on DME, complications in NPDR

W. Lloyd Clark discusses his presentation at ASRS 2021, "Impact of Nonperfusion and Leakage Areas on Diabetic Macular Edema/Vision-Threatening Complications in Nonproliferative Diabetic Retinopathy (NPDR)."

Celebrating World Sight Day 2021: How we #LoveYourEyes

On October 14, we celebrate World Sight Day by pledging to receive annual eye exams, preventing or slowing vision loss, and showing love for our eyes.